Vistagen Therapeutics, Inc.
VTGNDrugs in Pipeline
5
Phase 3 Programs
2
Upcoming Catalysts
2
Next Catalyst
Apr 15, 2026
18dMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
PH94B Nasal Spray
Social Anxiety Disorder
Fasedienol Nasal Spray
Social Anxiety Disorder (SAD)
AV-101
Major Depressive Disorder
PH94B
Adjustment Disorder With Anxious Mood
Fasedienol Nasal Spray - Fasedienol Nasal Spray
Social Anxiety Disorder
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PH94B Nasal Spray | Phase 3 | Social Anxiety Disorder | - | - |
Fasedienol Nasal Spray | Phase 3 | Social Anxiety Disorder (SAD) | - | - |
AV-101 | Phase 2 | Major Depressive Disorder | - | - |
PH94B | Phase 2 | Adjustment Disorder With Anxious Mood | - | - |
Fasedienol Nasal Spray - Fasedienol Nasal Spray | Phase 2 | Social Anxiety Disorder | - | - |
Social Anxiety Disorder
3 drugs in this indication
Major Depressive Disorder
1 drug in this indication
Adjustment Disorder With Anxious Mood
1 drug in this indication
Social Anxiety Disorder (SAD)
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)